EXPAND: Siponimod Benefits Secondary Progressive MS EXPAND: Siponimod Benefits Secondary Progressive MS

The new oral drug showed a ' moderate ' but significant reduction in disability progression in the largest-ever trial in secondary progressive multiple sclerosis, for which there are currently no well-proven treatments.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news